Observational analysis shows iron infusions are similarly effective and safe for pregnant women and non-pregnant women, suggesting comparable tolerability and symptom relief.
Key Points
Iron infusions effectively increased hemoglobin in pregnant women by 1.2g/dL and 1.8g/dL in non-pregnant women.
Safety analysis revealed infusion reactions in 3.3% of pregnant women, similar to 3.5% in non-pregnant women.
Pregnant women reported slightly more post-infusion discomfort symptoms at 16.6% compared to 8.5% in non-pregnant women.
Tolerability of iron infusions is overall consistent across both groups, indicating benefits exceed risks for pregnant women.